Interleukin-10 (IL-10) genotypes in inflammatory bowel disease

Citation
A. Tagore et al., Interleukin-10 (IL-10) genotypes in inflammatory bowel disease, TISSUE ANTI, 54(4), 1999, pp. 386-390
Citations number
30
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TISSUE ANTIGENS
ISSN journal
00012815 → ACNP
Volume
54
Issue
4
Year of publication
1999
Pages
386 - 390
Database
ISI
SICI code
0001-2815(199910)54:4<386:I(GIIB>2.0.ZU;2-5
Abstract
Interleukin-10 (IL-10) is an anti-inflammatory cytokine. Its production in humans is under genetic control, and genotype defines high or low producers of this cytokine. This study addresses the hypothesis that idiopathic infl ammatory bowel disease (IBD) patients are more likely to have the low IL-10 producer genotype and phenotype. DNA was extracted from blood cells of pat ients with Crohn's disease (CD) or with ulcerative colitis (UC) for IL-10 g enotyping. The frequency of the high IL-10 producer allele (-1082*G) was de creased in the whole IBD group (41% vs. 51%, P=0.03) and in the UC patients compared with normal controls (37% vs. 51%; P= 0.04). Hence, there appears to be an association between the IL-10 genotypes and IBD. This suggests th at individuals genetically predisposed to produce less PL-IO are at a highe r risk of developing LED, in particular, UC.